Medline Inc. shares are indicated to open 16% above their initial public offering price, after the medical supplier raised $6.26 billion in the year’s biggest listing. The shares are indicated at $33.50 each, versus the IPO price of $29. Medline, which counts Blackstone Inc., Carlyle Group Inc. and Hellman & Friedman among its backers, sold 216 million shares in an upsized offering that priced near the top of the marketed range. Most Read from Bloomberg Medline manufactures and distributes medical supp ...